ClinicalTrials.Veeva

Menu

Predicting Outcome of Transcutaneous Electrical Nerve Stimulator (TENS) in Failed Back Surgery Syndrome

U

Universitair Ziekenhuis Brussel

Status

Unknown

Conditions

Failed Back Surgery Syndrome

Treatments

Device: Sham-TENS
Device: TENS

Study type

Interventional

Funder types

Other

Identifiers

NCT01185665
vubmtmoensTENS

Details and patient eligibility

About

The study investigates the feasibility and efficacy of Transcutaneous Electrical Nerve Stimulator (TENS) in a subgroup of patients with neuropathic pain. Those patients are suffering of neuropathic pain at the lower back and leg after spinal surgery with a predominance of pain in the leg.

Full description

Derived from folk tradition, the notion that rubbing the skin over a painful area relieves pain, found scientific support in the gate-control theory proposed by Melzack and Wall 1. Since then, electrical stimulations for pain relief have spread worldwide.

The most known technique is Transcutaneous Electrical Nerve Stimulator (TENS). Surface electrodes are placed over the lower back (paravertebral at level L1-L2) it and the stimulation is delivered at high frequency and low intensity (below pain threshold), to produce an intense activation of Ab afferents and to evoke paresthesiae that cover the painful area.

In the literature about TENS in neuropathic pain a few controlled trials (classes II-IV) were found 2-8. The most studies dealt with painful diabetic neuropathy were very-high-frequency stimulation of lower-limb muscles were found more efficacious than standard TENS and low-frequency TENS or acupuncture-like more efficacious than sham stimulations.

Studies dealing with peripheral mononeuropathies found standard TENS better than placebo.

One crossover, small-sample study (class III) in painful cervical radiculopathy found that standard TENS applied to the cervical back was better than placebo but a TENS with random frequency variation was superior7. For chronic back pain no benefit was found for TENS compared to TENS-sham using a VAS and other outcome measures, but benefit was found comparing exercise to no exercise (Class I)9. In another Class I study, TENS vs TENS-sham was studied in patients with multiple sclerosis (MS) and chronic low back pain. After correction for multiple comparisons, there were no significant differences in the VAS or the secondary measures10. Both studies were adequately powered to find at least a 20% difference in pain reduction by VAS between TENS and TENS-sham. But in other articles no benefit were found for chronic back pain treated with TENS11,12. Therefore a recent report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology did not recommend TENS for the treatment of chronic low back pain due to lack of proven efficacy but TENS should be considered for the treatment of painful diabetic neuropathy 13

In our study design, we will investigate the feasibility and efficacy of TENS in a subgroup of patients with neuropathic pain. Those patients are suffering of neuropathic pain at the lower back and leg after spinal surgery with a predominance of pain in the leg.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Inclusions:

  • Age male/female patient ≥ 18 years
  • Patient diagnosed with Failed Back Surgery Syndrome with at least one prior spinal surgery
  • Patient with low back pain and/or pain in at least one leg
  • Pain intensity at baseline assessed by VAS > 5 (50%)

Exclusion criteria

Exclusions:

  • Formerly treated with TENS
  • Several unrelated sites of pain
  • Cognitive impairment
  • No help to replace electrodes
  • Ongoing litigation
  • Psychological intervention
  • Language difficulties
  • No informed consent
  • Existing or planned pregnancy
  • Age male/female patient <18 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups, including a placebo group

TENS
Active Comparator group
Description:
FBSS patients treated with TENS
Treatment:
Device: TENS
Sham-TENS
Placebo Comparator group
Description:
patients treated with Sham-Tens
Treatment:
Device: Sham-TENS

Trial contacts and locations

1

Loading...

Central trial contact

Maarten Moens, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems